Indications |
Topical/Cutaneous Corticosteroid-responsive dermatoses Adult: As propionate: Apply 0.05% cream/ointment onto affected area twice daily. Elderly: Initiate with lower dose. Renal impairment: Initiate with lower dose. Hepatic impairment: Initiate with lower dose. |
Contraindications |
Childn <12 yrs. Long-term treatment of ulcerative conditions, rosacea, pruritus; presence of acute infections. Hypersensitivity. |
Warnings / Precautions |
Heart failure, recent myocardial infarction, hypertension; diabetes mellitus; epilepsy; glaucoma; hypothyroidism; hepatic failure, renal impairment; psychoses; childn and elderly. Should not enter eyes. If infection exists, treat with specific anti-infectives. Pregnancy, lactation. |
Adverse Reactions |
Perioral dermatitis, striae esp in flexures. Dermal and epidermal atrophy esp on the face, steroid purpura. Potentially Fatal: Prolonged usage of large amount of clobetasol propionate can lead to sufficient systemic levels to produce adrenal suppression, Cushing's syndrome, diabetes and hypertension. |
Mechanism of Actions |
Clobetasol is a very potent corticosteroid used in short-term treatment of various inflammatory skin conditions. |
Storage Conditions |
Topical/Cutaneous: Store below 25°C. |
ATC Classification |
D07AD01 - clobetasol ; Belongs to the class of very potent (group IV) corticosteroids. Used in the treatment of dermatological diseases. |
Storage |
Topical/Cutaneous: Store below 25°C. |
Available As |
|
Clobetasol
Post Review about Clobetasol Click here to cancel reply.
Clobetasol Containing Brands
Clobetasol is used in following diseases
Drug - Drug Interactions of Clobetasol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.